Search

everythinglearnresearchcommunity

for

Search:↓

Intralesional triamcinolone acetonide is more effective than platelet-rich plasma for treating scalp alopecia areata.

Alopecia areata treatments often cause headaches and infections, highlighting the need for safer options.

Injectable therapy, especially with dutasteride, may help with hair loss, but more research is needed.

Botulinum A toxin injections reduced pain and promoted hair regrowth in a woman with a rare form of alopecia areata.

PRP works faster and is a safe alternative to steroids for treating alopecia areata.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

A method was found to visualize hair regrowth and avoid unnecessary side effects from treatments.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Alopecia Areata is an autoimmune hair loss condition that needs more research for better treatments.

Microneedle delivery of a special collagen shows promise for treating hair loss.

Narrowband UVB phototherapy alone is not very effective for treating alopecia areata.

Atopic dermatitis and alopecia areata share immune and genetic factors, and targeted therapies may help both.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

Topical tacrolimus is effective and safe for treating alopecia areata.

Using Excimer light with topical steroids is the most effective treatment for alopecia areata.

Ruxolitinib cream may help treat severe hair loss in children.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

CS12192 effectively treats alopecia areata with better safety than current options.

Alopecia areata involves complex immune responses, suggesting broader treatments could help.

Alopecia areata in Taif is common, mainly immune-related, and best treated with topical corticosteroids and vitamins.

Alopecia areata involves immune activation in the scalp, suggesting treatments targeting TH1, TH2, and IL-23 pathways.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

DM and AA may share a common cause.

Alopecia areata involves unique activation of certain immune cells.

Upadacitinib improves life quality for Alopecia Areata patients without worsening skin issues.